Académique Documents
Professionnel Documents
Culture Documents
VOLUME 7
NUMBER 2
Peptide Synthesis
COUPLING REAGENTS
NEW UNNATURAL
AMINO ACIDS
FLUOROUS PEPTIDE
SYNTHESIS
sigma-aldrich.com
2
tools for solution- and solid-phase peptide synthesis conveniently from a single source. You Milwaukee, WI 53209, USA
can choose between 2,100 natural and unnatural amino acid building blocks to design
your peptide, and select the coupling method for the most efficient synthesis. Finally,
you will find all required reagents for functionalization, manipulation and analysis of your To Place Orders
products. This ChemFiles highlights a comprehensive listing of coupling reagents available
Contact your local Sigma-Aldrich office
through Sigma-Aldrich and introduces new, unnatural amino acid building blocks, tools for
(see back cover), or visit www.sigma-aldrich.com
PEGylation, and products for fluorous-phase peptide synthesis and separation. For more
information, and access to our complete range of chemistry products, visit our Web site at
sigma-aldrich.com/gochem. Customer & Technical Services
If you are unable to find a building block, reagent or any other product for your Contact your local Sigma-Aldrich office
peptide synthesis projects, we welcome your request and will use it to broaden (see back cover), or visit www.sigma-aldrich.com
our product range even further. “Please Bother Us” with your suggestions at
matthias.junkers@europe.sial.com, or contact your local Sigma-Aldrich office (see
back cover). Subscriptions
To subscribe for your personal free copy of our
newsletters, please fill out attached reply card,
contact your local Sigma-Aldrich office (see back
RESEARCH IS EASIER WHEN YOU USE cover), or visit
www.sigma-aldrich.com/subscription.
THE RIGHT TOOLS!
ChemFiles are also available in PDF format on the
Internet at sigma-aldrich.com/chemfiles.
2007-2008 Aldrich Handbook
Sigma-Aldrich, Inc. warrants that its products
✓ 35’000 Chemical Listings
conform to the information contained in this and
✓ 10’000 Structures other Sigma-Aldrich publications. Purchaser must
✓ 2’000 NEW Products determine the suitability of the product for its
✓ 6’100 Citations particular use. See reverse side of invoice or packing
✓ 3’000 Application Notes slip for additional terms and conditions of sale.
✓ Enhanced Application Index
✓ Advanced Product Tables ChemFiles is a publication of Aldrich Chemical
Co., Inc. Aldrich is a member of the Sigma-Aldrich
Group. © 2007 Sigma-Aldrich Co.
amino acids are represented as their unprotected derivatives). The generated D-Ala-D-Ala
dipeptide is the main recognition sequence for the powerful antibiotic vancomycin.
During the coupling reaction the nucleophilic amino group of one D-alanine attacks the
-OAt-activated carbonyl group of another D-alanine. In the process, the pyridine nitrogen
of the -OAt-moiety accelerates the aminolysis of the active ester through intramolecular
base catalysis. This neighbouring group effect explains the high efficiency of HOAt derived
peptide coupling reagents like HATU.
3
Coupling Reagents
efficiency and suitability for specific applications (e.g., solid-phase The generation of an acid chloride is an obvious way to activate
peptide synthesis or fragment condensation). the carboxy group for amide bond formation. However, practical
application of acid chlorides in peptide synthesis is restricted,
Amino Acid I Amino Acid II Dipeptide
O because they are prone to side reactions and racemization. In spite
H2 N
O
PGO peptide bond of this disadvantage, acid chlorides are frequently recommended
2
PG 2 2
PG R1 1
2
PG
R2 O
to link extremely hindered or achiral amino acids. 1-Chloro-N,N,2-
R R2 PG H
PGN OH PGN N PGO trimethyl-1-propenylamine, developed by Ghosez, enables the
N PGN X N O
H
O
N
H -HX H
O R1 conversion of carboxylic acids into the corresponding chlorides
O PG1
Activation Coupling under strictly neutral conditions.1 This method was successfully
applied by Fürstner in the total synthesis of Caloporoside and
Scheme: Simplified general mechanism of peptide bond formation.
Roseophilin.2
All coupling methods have the same reaction principle in common:
The most notable advance in acid halogenation has been the
after activation of the carboxy group of the first amino acid, the
introduction of fluoroamidinium salts by Carpino.3 Compared to
second amino acid can form the peptide bond by a nucleophilic
the chlorides, the acid fluorides show greater stability towards
attack of its amino group. In order to prevent uncontrolled
water and a relative lack of conversion to the corresponding
peptide bond formation the amino group of the first amino acid
oxazolones upon treatment with organic bases. TFFH (Fluoro-
and all functional side chain groups need to be reversibly blocked.
N,N,N’,N’-tetramethylformamidinium hexafluorophosphate)
Repeated de-blocking, activation, and coupling build the peptide
and BTFFH (Fluoro-N,N,N’,N’-bis(tetramethylene)formamidinium
to its desired final sequence.
hexafluorophosphate) are stable, non-hygroscopic salts. They act
A broad variety of coupling reagents available through in situ as fluorinating reagents and are suitable both for solution
Sigma-Aldrich will be presented and discussed. For further syntheses and for SPPS (Solid-Phase Peptide Synthesis).
reading, detailed reviews are available.1,2
References: (1) Haveaux, B.; Dekoker, A.; Rens, M.; Sidani, A. R.; Toye, J.; Ghosez, K.
References: (1) Goodman, M. Methods of Org. Chem. (Houben-Weyl) add. and suppl. Org. Synth. 1980, 59, 26. (2) Fürstner, A.; Konetzki, I. J. Org. Chem. 1998, 63, 3072.
vol. to the 4th ed., Vol. E 22 a, 2002, pp. 425–888. (2) Han, S.-Y.; Kim, Y.-A. Tetrahedron (3) Carpino, L. A.; El-Faham, A. J. J. Am. Chem. Soc. 1995, 117, 5401.
2002, 60, 2447.
1-Chloro-N,N,2-trimethyl-1-propenylamine, 96%
Azide Formation (CH3)2C=C(Cl)N(CH3)2
Azide coupling procedures were introduced by Curtius as one FW: 133.62 N
For a long time they were thought to be the only racemisation 498270-5ML 5 mL
free method. A very convenient way to form N-acylamino acid
azides is to apply DPPA (diphenyl phosphoryl azide). This method Chloro-N,N,N’,N’-bis(tetramethylene)formamidinium
is particularly useful in cyclization reactions of peptides.1,2 DPPA tetrafluoroborate, purum, >97.0% (AT)
can also be used in the preparation of urethanes by reaction with C9H16BClF4N2 Cl
alcohols. FW: 274.49 BF4-
N N+
[115007-14-2]
References: (1) Hoffmann, E.; Beck-Sickinger, A. G.; Jung, G. Liebigs Ann. Chem 1991,
585. (2) Yamada, T.; Omote, Y.; Nakamura, Y.; Miyazawa, T.; Kuwata, S. Chem. Lett. 23957-1G-F 1g
1993, 1583.
23957-5G-F 5g
23957-25G-F 25 g
Diphenyl phosphoryl azide, purum, >98.0%
DPPA O
O
PyClU, purum, >98.0% (CHN)
(C6H5O)2P(O)N3 P N3
O C9H16N2Cl · PF6 Cl
FW: 275.2 FW: 332.65 N N+ PF6-
[26386-88-9] [135540-11-3]
72935-10ML-F 10 mL
23955-1G-F 1g
72935-50ML-F 50 mL
23955-5G-F 5g
Diphenyl phosphoryl azide, 97% 23955-25G-F 25 g
DPPA O
O
(C6H5O)2P(O)N3 P N3 Chloro-N,N,N’,N’-tetramethylformamidinium
FW: 275.2
O hexafluorophosphate, purum, >98.0% (T)
[26386-88-9] C5H12ClF6N2P Cl
FW: 280.58 PF6-
178756-5G 5g N N+
[207915-99-9]
178756-25G 25 g
178756-100G 100 g 09658-5G 5g
09658-25G 25 g
To discuss how our expertise can benefit your next scale-up project or to obtain a quote,
contact your local Sigma-Aldrich office or visit www.safcglobal.com
4
Fluoro-N,N,N’,N’-tetramethylformamidinium Fluoro-N,N,N’,N’-bis(tetramethylene)formamidinium
hexafluorophosphate, puriss., >99.0% hexafluorophosphate, >99.0%
TFFH BTFFH
F F
[FC[=N(CH3)2]N(CH3)2]PF6 C9H16F7N2P
+ PF6- N N+ PF6-
FW: 264.12 N N FW: 316.2
[164298-23-1] [164298-25-3]
47440-1G-F 1g 17380-5G 5g
47440-5G-F 5g 17380-25G 25 g
Fluoro-N,N,N’,N’-tetramethylformamidinium
Coupling Reagents
hexafluorophosphate, 97%
TFFH
F
[FC[=N(CH3)2]N(CH3)2]PF6
N+ PF6-
FW: 264.12 N
[164298-23-1]
520330-1G 1g
520330-5G 5g
the environment.
330752-5G 5g
References: (1) Babad, H.; Zeiler, A. G. Chem. Rev. 1973, 73, 75. (2) Eckert, H.; Forster, 330752-25G 25 g
B. Angew. Chem. Int. Ed. 1987, 26, 894. 330752-100G 100 g
Cartridge for Phosgene Generation, Starter Kit 8 Phosgene solution, purum, ~20% in toluene
Contains one 0.02 mole cartridge (519758), hose connector with COCl2
O
sealing lips, Viton tubing, dosimeter badge, and instructions for use. FW: 98.92 C
[75-44-5] Cl Cl
519782-1KT 1 Kit
79380-100ML 100 mL
79380-500ML 500 mL
Thiophosgene, 97%
CSCl2
S
FW: 114.98 C
[463-71-8] Cl Cl
115150-5G 5g
115150-25G 25 g
115150-100G 100 g
C
[463-71-8] Cl Cl
89030-25ML 25 mL
89030-100ML 100 mL
Coupling Reagents
water. The most popular carbodiimide of this kind is EDC (N-(3-
Dimethylaminopropyl)-N’-ethylcarbodiimide). Furthermore EDC bound, 200–400 mesh, extent of labeling: 0.5–1.5 mmol/g
or EDAC allow peptide coupling in alcohol or aqueous solutions loading, 2% cross-linked with divinylbenzene
EDC, WSC
involving proteins or peptide cyclizations.1 CH3
N N
C CH3
In solid-phase peptide synthesis, diisopropylcarbodiimide (DIC) H3C N
C6H11N=C=NC6H11 N
[22572-40-3]
C
FW: 206.33 N 165344-1G 1g
[538-75-0] 165344-10G 10 g
36650-100G 100 g
36650-500G 500 g N-(3-Dimethylaminopropyl)-N’-ethylcarbodiimide
36650-2.5KG 2.5 kg hydrochloride, BioChemika, >99.0%
EDC hydrochloride, EDAC
CH3
N,N’-Dicyclohexylcarbodiimide, 99.0% C8H17N3 · HCl N N HCl
C6H11N=C=NC6H11 [25952-53-8]
N
C
FW: 206.33 N 03449-1G 1g
[538-75-0] 03449-5G 5g
D80002-25G 25 g 03449-25G 25 g
D80002-100G 100 g
D80002-1KG 1 kg N-(3-Dimethylaminopropyl)-N’-ethylcarbodiimide
hydrochloride, SigmaUltra
N,N’-Dicyclohexylcarbodiimide solution, purum, ~1 M in EDC hydrochloride, EDAC
CH3
methylene chloride C8H17N3 · HCl N N HCl
C6H11N=C=NC6H11 [25952-53-8]
N
C
FW: 206.33 N E1769-1G 1g
[538-75-0] E1769-5G 5g
36652-100ML 100 mL E1769-10G 10 g
E1769-25G 25 g
N,N’-Dicyclohexylcarbodiimide solution, 1.0 M in methylene
chloride N-(3-Dimethylaminopropyl)-N’-ethylcarbodiimide
DCC hydrochloride, purum, >98.0%
C6H11N=C=NC6H11 N EDC hydrochloride, EDAC
C CH3
FW: 206.33 N C8H17N3 · HCl HCl
N N
[538-75-0] FW: 191.7 H3C N
C CH3
[538-75-0]
36651-100ML-F 100 mL
36651-250ML-F 250 mL
To discuss how our expertise can benefit your next scale-up project or to obtain a quote,
contact your local Sigma-Aldrich office or visit www.safcglobal.com
6
E7750-5G 5g 29470-5G 5g
E7750-10G 10 g 29470-25G 25 g
E7750-25G 25 g
E7750-100G 100 g N-Cyclohexyl-N’-(2-morpholinoethyl)carbodiimide metho-p-
Coupling Reagents
N-Cyclohexyl-N’-(2-morpholinoethyl)carbodiimide metho-p-
toluenesulfonate, puriss., >99.0%
CMC
CH3
C14H26N3O · C7H7O3S C
N
N+ -O3S CH3
N
FW: 423.57
[2491-17-0] O
29469-5G 5g
29469-25G 25 g
Coupling Reagents
for highly toxic phosgene in the preparation of carbamates and DMC
Cl
ureas from alcohols and amines.2,3 C5H10Cl2N2
FW: 169.05 N N+ Cl-
Kiso developed modified imidazolium reagents like CIP (2-Chloro-
[37091-73-9]
1,3-dimethylimidazolidinium hexafluorophosphate) as new peptide
coupling reagents and later as new esterification reagents to avoid 24374-10G-F 10 g
the toxic HMPA by-product of the BOP reagent (benzotriazol-1- 24374-50G-F 50 g
yloxytris(dimethylamino)phosphonium hexafluorophosphate).4 CIP
was successfully applied to the coupling of a,a-dialkylated amino 2-Chloro-1,3-dimethylimidazolidinium chloride
acids and proved to be especially efficient in combination with DMC
Cl
HOAt (1-hydroxy-7-azabenzotriazole).5 C5H10Cl2N2
FW: 169.05 N N+ Cl-
References: (1) Staab, H. A. Angew. Chem. Int. Ed. Engl. 1962, 1, 351. (2) Staab, H. [37091-73-9]
A. Justus Liebigs Ann. Chem. 1957, 609, 83. (3) Staab, H. A. Justus Liebigs Ann. Chem.
1957, 609, 75. (4) Akaji, K.; Kuriyama, N.; Kimura, T.; Fujiwara, Y.; Kiso, Y. Tetrahedron
529249-25G 25 g
Lett. 1992, 33, 3177. (5) Albericio, A.; Bailén, F. M.; Chinchilla, R.; Dodsworth, D. J.;
Nájera, C. Tetrahedron 2001, 57, 9607. 2-Chloro-1,3-dimethylimidazolidinium tetrafluoroborate,
purum, >96.0%
1,1’-Carbonyldiimidazole, reagent grade CIB
Cl
CDI C5H10BClF4N2
FW: 220.40 N N+ BF4-
C7H6N4O N N N N
FW: 162.15 [153433-26-2]
O
[530-62-1] 24377-1G-F 1g
115533-5G 5g 24377-5G-F 5g
115533-10G 10 g
115533-25G 25 g 2-Chloro-1,3-dimethylimidazolidinium hexafluorophosphate,
115533-100G 100 g purum, >98.0%
CIP
Cl
C5H10ClF6N2P
1,1’-Carbonyldiimidazole, purum, >97.0% FW: 278.56 N N+ PF6-
CDI [101385-69-7]
C7H6N4O N N N N
FW: 162.15 24375-1G-F 1g
O 24375-5G-F 5g
[530-62-1]
21860-5G 5g 24375-25G-F 25 g
21860-25G 25 g
2-Chloro-1,3-dimethylimidazolidinium hexafluorophosphate,
21860-100G 100 g
98%
CIP
1,1’-Carbonyl-di-(1,2,4-triazole), technical, >90% C5H10ClF6N2P
Cl
CDT FW: 278.56 N N+ PF6-
N N
C5H4N6O N N N N
[101385-69-7]
FW: 164.12
[41864-22-6]
O 420336-1G 1g
420336-5G 5g
21861-5G 5g
2-Fluoro-1,3-dimethylimidazolidinium hexafluorophosphate,
1,1’-Carbonyl-di-(1,2,4-triazole), ~90%
puriss., >98.5%
CDT
N N DFIH
C5H4N6O N N N N F
C5H10F7N2P
FW: 164.12 N+ PF6-
O FW: 262.11 N
[41864-22-6]
[164298-27-5]
C2956-5G 5g
17381-5G 5g
17381-25G 25 g
Oxalic acid diimidazolide, technical, >90% (NT)
C8H6N4O2 O O
FW: 190.16 N N
[18637-83-7]
N N
75749-5G 5g
75749-25G 25 g
To discuss how our expertise can benefit your next scale-up project or to obtain a quote,
contact your local Sigma-Aldrich office or visit www.safcglobal.com
8
BOP and it has become widely used.1,2 Since the utilization of 12805-25G-F 25 g
BOP involves the handling of the toxic and carcinogenic HMPA,
the viable alternative PyBOP has been developed where the (7-Azabenzotriazol-1-yloxy)tripyrrolidinophosphonium
dimethylamino groups are replaced by pyrrolidine substituents. hexafluorophosphate, 96%
PyBOP shows comparable performance to BOP, in some cases even PyAOP N
N
better.3 Numerous other variations of BOP have been reported C17H27F6N7OP2 N N PF6-
N
among which the HOAt analogue to PyBOP, PyAOP, excels FW: 521.38 O P+ N
especially in the coupling of sterically hindered amino acids.4 [156311-83-0] N
(Benzotriazol-1-yloxy)tris(dimethylamino)phosphonium Bromotris(dimethylamino)phosphonium
hexafluorophosphate, purum, >98.0% hexafluorophosphate, 98%
BOP, Castro’s reagent N H3C CH3 BroP H3C CH3
N CH3 N
C12H22F6N6OP2 N
PF6- BrP[N(CH3)2]3PF6 H3C
N P+ N CH3 N P+ Br PF6-
FW: 442.28 O
N
FW: 388.07 H3C
N
[56602-33-6] H C CH3
3 [50296-37-2] H3C CH3
DEPBT O
O
C11H14N3O5P N
O
P O
CH3
FW: 299.22 N
N O
[165534-43-0] CH3
495964-5G 5g
Uronium and Guanidinium Salts with greater stability in aqueous solvent mixtures allowing the
modification of proteins.8
The special need of SPPS for rapid and highly efficient coupling
reagents led to the development of several new reagents starting The new thiouronium reagent TOTT (S-(1-Oxido-2-pyridyl)-
from BOP (Benzotriazol-1-yloxytris(dimethylamino)phosphonium N,N,N’,N’-tetramethylthiuronium tetrafluoroborate) is ideally suited
hexafluorophosphate). The HOBt (N-Hydroxybenzotriazole) for the rapid and high-yielding preparation of primary amides
derived components HBTU and TBTU today belong to the when reacted with carboxylic acids and ammonium chloride.9
most widely used reagents for peptide coupling and feature References: (1) Carpino, L. A. et al. Angew. Chem. Int. Ed. 2002, 41, 441. (2) Uhlmann,
a broad application spectrum. HBTU and TBTU differ only by E.; Peymann, A.; Breipohl, G.; Will, D. W. Angew. Chem. Int. Ed. 1998, 37, 2796. (3)
their counterions hexafluorophosphate or tetrafluoroborate, Kamencka, T. M.; Danishefsky, S. J. Chem. Eur. J. 2001, 7, 41. (4) Chen, S.; Xu, J. Tetrahe-
dron Lett. 1992, 33, 647. (5) Sabatino, G.; Mulinacci, B.; Alcaro, M.C.; Chelli, M.; Rovero,
Coupling Reagents
respectively. A comparison study showed that these anions have P.; Papini, A.M. Lett. Pept. Sci. 2002, 9, 119. (6) Pon, R. T.; Yu, S.; Sanghvi, Y. S. J. Org.
no significant influence on the coupling rate or racemization. Chem. 2002, 67, 856. (7) Knorr, R. et al. Tetrahedron Lett. 1989, 30, 1927. (8) Knorr, R.;
Trzeciak, A.; Bannwarth, W.; Gillessen, D. Peptides 1990, 62. (9) Bailin, M. A. et al. J.Org.
For a long time, the active HBTU and its family were believed Chem. 1999, 64, 8936.
to possess an uronium structure, but intensive studies provided
evidence for the formulation of guanidinium N-oxides.1 O-(Benzotriazol-1-yl)-N,N,N’,N’-tetramethyluronium
Nevertheless, by custom, they are still called uronium type hexafluorophosphate, purum, >98.0%
reagents. Unlike carbodiimides or phosphonium reagents, uronium HBTU
salts could form tetramethylguanidinium derivatives with free C11H16F6N5OP
N
N+ PF6-
amines. To circumvent this side reaction, excess reagent should FW: 379.24 N
N
be avoided and pre-activation of the carboxylic acid component is [94790-37-1] N+
recommended. O-
12804-1G-F 1g
Besides HBTU and TBTU, several other members of the uronium
family are worthy of attention. The 7-aza-analogue of HBTU called 12804-5G-F 5g
HATU (1-[Bis-(dimethylamino)methyliumyl]-1H-1,2,3-triazolo[4,5- 12804-25G-F 25 g
b]pyridine-3-oxide hexafluorophosphate) can be considered today’s
O-(Benzotriazol-1-yl)-N,N,N’,N’-tetramethyluronium
gold standard of peptide coupling reagents. It has been used for
tetrafluoroborate, 97%
difficult amide bond formation in solution and solid-phase (e.g., TBTU
PNAs) synthesis.2 It is especially superior for macrocyclization, C11H16N5O · BF4 N
N+ BF4-
fragment condensation, and the coupling of N-substituted FW: 321.08 N
amino acids. Danishefsky reported an impressive example for [125700-67-6]
N
N+
the application of HATU in a late step of the total synthesis of O-
Hemastatin with HATU simultaneously connecting two peptide 12806-5G-F 5g
macrocycles.3 12806-25G-F 25 g
12806-100G-F 100 g
H OTBS 12806-250G-F 250 g
TBSO HN N TrocHN
H
H N
O
O TESO CO2H O O-(7-Azabenzotriazol-1-yl)-N,N,N’,N’-tetramethyluronium
O N H
N N O
hexafluorophosphate, purum, >98.0%
H O N N N
O HO2C OTES O O
N H
O HATU
H N
NHTroc N NH OTBS C10H15F6N6OP N+ PF6-
TBSO H
FW: 380.23 N
N
[148893-10-1] N+
N
O-
1. Pb/Cd, THF, aq NH4OAc, 1.5 h
34 % for 3 steps 2. HATU, HOAt, DIEA, DMF, rt, 28 h 11373-1G 1g
3. TBAF, AcOH, THF, rt, 55 h 11373-5G 5g
11373-25G 25 g
H OTBS
N
TBSO
HN H HN O-(7-Azabenzotriazol-1-yl)-N,N,N’,N’-tetramethyluronium
H N H
O
O
O TESO O
O
O N
N hexafluorophosphate, 97%
N
N N O N O O
HATU
H O OTES N
O O OTBS C10H15F6N6OP N+ PF6-
N H
NH H NH FW: 380.23 N
N
TBSO H N
[148893-10-1] N N+
O-
445460-1G 1g
Scheme: Application of HATU in the simultaneous cyclization of two linked
peptide strands for the synthesis of Hemastatin.
445460-5G 5g
445460-25G 25 g
Substitution of HBTU’s dimethylamino groups by pyrrolidine
residues as in HBPyU leads to less racemization during peptide O-(Benzotriazol-1-yl)-N,N,N’,N’-bis(tetramethylene)uronium
coupling.4 Introducing an electron-withdrawing group into the hexafluorophosphate, purum, >98.0%
benzotriazole moiety enhances the reactivity. Accordingly HCTU HBPyU N
N
and TCTU show improved performance in difficult or hindered C15H20F6N5OP N
N+ PF6-
couplings and cyclizations when compared to HBTU.5 HCTU has FW: 431.32 O
To discuss how our expertise can benefit your next scale-up project or to obtain a quote,
contact your local Sigma-Aldrich office or visit www.safcglobal.com
10
O-Benzotriazol-1-yl-N,N,N’,N’-bis(pentamethylene)uronium O-[(Ethoxycarbonyl)cyanomethylenamino]-N,N,N’,N’-
hexafluorophosphate, 98% tetramethyluronium tetrafluoroborate, purum, >98.0%
HBPipU N TOTU CN
N
C17H24F6N5OP N
C2H5O2CC(CN)=NOC[N(CH3)2]=N(CH3)2BF4 O O N+ BF4-
N+ PF6- N
FW: 459.37 O FW: 328.07 O N
[190849-64-0] N [136849-72-4]
02580-1G 1g
420271-1G 1g 02580-5G 5g
02580-25G 25 g
8
Coupling Reagents
O-(6-Chlorobenzotriazol-1-yl)-N,N,N’,N’-
tetramethyluronium hexafluorophosphate, purum, >98.0% O-[(Ethoxycarbonyl)cyanomethylenamino]-N,N,N’,N’-
HCTU N tetramethyluronium tetrafluoroborate, 98%
C11H15ClF6N5OP N TOTU CN
Cl N
N+ PF6- C2H5O2CC(CN)=NOC[N(CH3)2]=N(CH3)2BF4
FW: 413.69 O O
N
O N+ BF4-
[330645-87-9] N FW: 328.07 O N
[136849-72-4]
04936-5G-F 5g
382469-1G 1g
04936-25G-F 25 g
382469-5G 5g
04936-100G-F 100 g
N,N,N’,N’-Tetramethyl-O-(N-succinimidyl)uronium
O-(6-Chlorobenzotriazol-1-yl)-N,N,N’,N’- 8 hexafluorophosphate, purum, >99.0%
tetramethyluronium, purum, >98.0% HSTU O
TCTU N
C9H16F6N3O3P
N N O N+ PF6-
C11H15BClF4N5O Cl N FW: 359.21
N+ BF4-
FW: 355.53 O
[265651-18-1] O N
[330641-16-2] N
09668-1G 1g
78133-5G-F 5g 09668-5G 5g
78133-25G-F 25 g 09668-25G 25 g
78133-100G-F 100 g
N,N,N’,N’-Tetramethyl-O-(N-succinimidyl)uronium
O-(3,4-Dihydro-4-oxo-1,2,3-benzotriazin-3-yl)-N,N,N’,N’- tetrafluoroborate, 97%
tetramethyluronium tetrafluoroborate, purum, >99.0% TSTU O
TDBTU C9H16BF4N3O3
O N O N+ BF4-
C12H16BF4N5O2 O N+ BF4-
FW: 301.05
N N
FW: 349.09 [105832-38-0] O
N N
N
[125700-69-8] 385530-1G 1g
37345-1G-F 1g 385530-5G 5g
37345-5G-F 5g
37345-25G-F 25 g Dipyrrolidino(N-succinimidyloxy)carbenium , purum, >98.0%
HSPyU O
Coupling Reagents
Cyanuric chloride has been used for the preparation of acyl
chlorides, amides and peptides. The cyanuric chloride derivative 2-Chloro-1-methylpyridinium iodide, purum, >97.0% (AT)
CDMT (2-chloro-4,6-dimethoxy-1,3,5-triazine) yields highly reactive C6H7ClIN I-
esters with carboxylic acids that can then be used as powerful FW: 255.48 N+ Cl
acylating agents for amines and the less nucleophilic, alcohols.4 [14338-32-0] CH3
The activation is performed in presence of a base, preferentially 25270-25G 25 g
NMM (N-methylmorpholine). In situ NMM and CDMT form the
25270-100G 100 g
intermediate DMTMM. DMTMM can be isolated and used as
coupling reagent independently.5 In contrast to CDMT, DMTMM
2-Chloro-1-methylpyridinium iodide, 97%
does not require pre-activation of the carboxylic acid. The coupling
C6H7ClIN I-
efficiency of DMTMM in SPPS was found to be comparable to FW: 255.48 N+ Cl
PyBOP while racemization could be kept below the detection [14338-32-0] CH3
limit.6
198005-10G 10 g
References: (1) T3P is a registered trademark of Clariant. (2) Klose, J. et al. Chem. Com-
198005-25G 25 g
mun. 1999, 1847. (3) Berrien, J.-F.; Billon, M.-A.; Husson, H.-P. J. Org. Chem. 1995, 60,
2922. (4) Kaminski, Z. J. Synthesis 1987, 917. (5) Kaminski, Z. J.; Paneth, P.; Rudzinski, J. 198005-100G 100 g
J. Org. Chem. 1998, 63, 4248. (6) Falchi, A.; Giacomelli, G.; Porcheddu, A.; Taddei, M.
Synlett 2000, 275.
2-Chloro-4,6-dimethoxy-1,3,5-triazine, purum, >98.0%
CDMT NMM DMTMM CDMT Cl
O C5H6ClN3O2
Cl Cl- N N
THF, FW: 175.57 H3C CH3
O N+ O N O
N N rt, 30 min [3140-73-6]
+
N N 24320-5G-F 5g
MeO N OMe N 100 %
MeO N OMe 24320-25G-F 25 g
81799-10ML 10 mL
81799-50ML 50 mL
81799-250ML 250 mL
To discuss how our expertise can benefit your next scale-up project or to obtain a quote,
contact your local Sigma-Aldrich office or visit www.safcglobal.com
12
trans-2-(Fmoc-amino)-cyclohexanecarboxylic acid, 8
b-amino Acids purum, >98.0% (HPLC)
C22H23NO4 O OH
(cis)-3-Aminobicyclo[2.2.1]heptane-2-carboxylic acid 8 FW: 365.42 H
N
hydrochloride, purum, >98.0% (TLC) [381241-08-3] Fmoc
19578-500MG-F 500 mg
43667-500MG 500 mg
Boc-(R)-4-[2-(trifluoromethyl)benzyl]-L-proline, 8
purum, >98.0% (HPLC)
Boc-3-(1,2,4-triazol-1-yl)-Ala-OH, purum 8 C18H22F3NO4 CF3
C10H16N4O4 O FW: 373.37 OH
FW: 256.26 N
N OH
HN N O
N BOC BOC
Amino Acids
New Unnatural
50996-500MG-F 500 mg 38455-500MG-F 500 mg
01336-500MG-F 500 mg
Boc-4,5-dehydro-Leu-OH dicyclohexylamine salt, 8
purum, >96.0% (HPLC) Boc-(R)-a-(4-fluorobenzyl)-Pro-OH, purum, 8
C11H19NO4 · C12H23N O H >98.0% (HPLC)
N
FW: 410.59 OH C17H22FNO4 F
[87720-54-5] HN FW: 323.36
BOC
[706806-64-6]
11578-50MG 50 mg
OH
N
Fmoc-3-(1,2,4-triazol-1-yl)-Ala-OH, purum, 8 BOC O
>97.0% (HPLC)
67420-500MG-F 500 mg
C20H18N4O4 O
FW: 378.38 N
N OH
HN Boc-(R)-a-(4-tert-butylbenzyl)-Pro-OH, purum, 8
N Fmoc
>97.0% (HPLC)
53229-500MG-F 500 mg C21H31NO4
FW: 361.48
Fmoc-3-(1-pyrazolyl)-Ala-OH, purum, >97.0% (HPLC) 8
C21H19N3O4 O
FW: 377.39 N
N OH
OH
N
HN
Fmoc BOC O
42004-500MG-F 500 mg
Proline Derivatives
N(R)-a-Allyl-proline hydrochloride, purum, 8 Boc-(R)-a-allyl-Pro-OH, purum, >98.0% (HPLC) 8
>98.0% (TLC) C13H21NO4
C8H13NO2·HCl FW: 255.31 OH
To discuss how our expertise can benefit your next scale-up project or to obtain a quote,
contact your local Sigma-Aldrich office or visit www.safcglobal.com
14
OH Miscellaneous
N
BOC O
(S)-6-Oxo-2-piperidinecarboxylic acid, purum, 8
39166-500MG-F 500 mg >97.0% (HPLC)
C6H9NO3
Boc-(S)-a-(4-trifluoromethylbenzyl)-Pro-OH, purum, 8 FW: 143.14 OH
O N
>98.0% (HPLC) [34622-39-4] H
O
C18H22F3NO4 CF3 36323-1G-F 1g
FW: 373.37 36323-5G-F 5g
OH 2-[2-(Boc-amino)ethoxy]ethoxyacetic acid 8
N
O dicyclohexylamine salt, purum, >98.0% (TLC)
BOC
C11H21NO6 · C12H23N H
05199-500MG-F 500 mg N
FW: 444.61 BOC
N
O
O
OH
H
O
14766-500MG-F 500 mg
Cartridge for Phosgene Generation, 0.05 mole COCl2 98.92 75-44-5 519766-1PAK
519766-5PAK
Peptide PEGylation
New Tools for
HOOCCH2CH2CONH(CH2
O O
tert-Butyl 12-amino-4,7,10-trioxadodecanoate 8 CH2O)nCH2CH2NHCOCH2 H
N O OH
C13H27NO5 CH2COOH HO O
n
N
H
O O
FW: 277.36
O Mr 3000
H2N O
O O O
[252881-74-6] 14567-250MG 250 mg
83060-1G-F 1g
83060-5G-F 5g Hycron linker 8
C17H31BrO6
O
O,O’-Oxydiethylene-diglycolic acid 8 FW: 411.33 O O
[166668-33-3] Br O O O
C8H14O7
O O
[13887-98-4] O O 96823-1G-F 1g
HO O OH
96823-5G-F 5g
92893-50ML 50 mL
92893-250ML 250 mL O,O’-Bis(2-aminoethyl)octadecaethylene glycol, 8
>95% (oligomer purity)
{2-[2-(Fmoc-amino)ethoxy]ethoxy}acetic acid, 8 C40H84N2O19
FW: 897.1 H2N O
purum, >95.0% O
18
NH2
C21H23NO6
O
FW: 385.41 H
N O 06703-1G-F 1g
[166108-71-0] Fmoc O OH
14571-1G 1g
15879-1G-F 1g
15879-5G-F 5g
To discuss how our expertise can benefit your next scale-up project or to obtain a quote,
contact your local Sigma-Aldrich office or visit www.safcglobal.com
16
O-(2-tert-Butyloxycarbonylethyl)dodecaethylene 8 O-[2-(Fmoc-amino)-ethyl]-O’-(2-carboxyethyl) 8
glycol, >95% (oligomer purity) polyethylene glycol 3000
C31H62O15 H
O O
FW: 674.81 HO
12 Fmoc
N
O
O OH
n
O O
08453-500MG-F 500 mg
669717-100MG 100 mg
669717-500MG 500 mg
Methoxypolyethylene glycol 5,000 acetic acid, 8
BioChemika, >80%
Octacosaethylene glycol 8
O HO(CH2CH2O)28H
H3C O
O
n
OH FW: 1251.49 HO
O
H
28
70718-1G-F 1g
672351-500MG 500 mg
70718-5G-F 5g
70718-25G-F 25 g
O-(2-Mercaptoethyl)-O’-methyl-hexa(ethylene glycol) 8
C15H32O7S
Methoxypolyethylene glycol 5,000 propionic acid, 8
New Tools for
Peptide PEGylation
H3C O OH
672572-250MG 250 mg
O
n
O
O-(2-Carboxyethyl)-O’-(2-mercaptoethyl) 8
88908-1G-F 1g heptaethylene glycol
88908-5G-F 5g C19H38O10S O
88908-25G-F 25 g FW: 458.56 HO O
O
SH
7
93113-1G-F 1g
671363-100MG 100 mg
O-(2-Aminoethyl)-O’-[2-(Boc-amino)ethyl] 8 671363-500MG 500 mg
polyethylene glycol 5000
H2N O BOC
O N
n H
671266-100MG 100 mg
671266-500MG 500 mg
Got ChemNews?
s i g m a - a l d r i c h . c o m
sigma-aldrich.com/chemnews
Fluorous
FINISHED PEPTIDE
cap-tags
Synthesis
Fluorous Peptide
Fluorous Peptide Coupling Tools Fluorous Protecting Groups
2-Chloro-4,6-bis[3-(perfluorohexyl)propyloxy]- 8 2,7-Bis(1H,1H,2H,2H-perfluorooctyl)-9- 8
1,3,5-triazine fluorenylmethoxycarbonyl-chlorid
C21H12ClF26N3O2 Cl C31H17ClF26O2
F3C(F2C)5 (CF2)5CF3
FW: 867.75 N N FW: 950.88
F3C(F2C)5 O N O (CF2)5CF3
O
672378-1G 1g Cl O
672262-1G 1g
4-(3,3,4,4,5,5,6,6,7,7,8,8,8-Tridecafluorooctylthio) 8
phenol, >97% 2-[(4,4,5,5,6,6,7,7,7-Nonafluoro-1,1-dimethylheptyloxy)-
C14H9F13OS OH
carbonyloxyimino]-2-phenylacetonitrile
FW: 472.26
C18H15F9N2O3 O
FW: 478.31 NC N
O O (CF2)3CF3
S
(CF2)5CF3
43893-1G-F 1g 01382-1G-F 1g
43893-5G-F 5g
2-[(4,4,5,5,6,6,7,7,8,8,9,9,9-Tridecafluoro-1,1-
4-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10- 8 dimethylnonyloxy) carbonyloxyimino]-2-phenylacetonitrile
Heptadecafluorodecylthio)phenol, >97% C20H15F13N2O3 O
NC N
C16H9F17OS OH
FW: 578.32 O O (CF2)5CF3
FW: 572.28
S 11807-1G-F 1g
11807-5G-F 5g
(CF2)7CF3
40829-1G-F 1g 2-[(4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-Heptadecafluoro-1,1-
40829-5G-F 5g dimethylundecyloxy)carbonyloxyimino]-2-phenylacetonitrile
C22H15F17N2O3
FW: 678.34 O
NC N
[350716-42-6] O O (CF2)7CF3
55118-1G-F 1g
55118-5G-F 5g
To discuss how our expertise can benefit your next scale-up project or to obtain a quote,
contact your local Sigma-Aldrich office or visit www.safcglobal.com
18
N-[4-(3,3,4,4,5,5,6,6,6-Nonafluorohexyl) 4-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-Heptadecafluorodecyl)-
benzyloxycarbonyloxy]succinimide benzyl alcohol, >98.0%
C18H14F9NO5 O C17H11F17O
O OH
FW: 495.29 N
FW: 554.24
O O
[356055-77-1] F3C(F2C)7
O
F3C(F2C)3
19563-1G-F 1g
00246-1G-F 1g 19563-5G-F 5g
N-[4-(3,3,4,4,5,5,6,6,7,7,8,8,8-Tridecafluorooctyl) 1-(4-Methoxyphenyl)-1-[4-(1H,1H,2H,2H- 8
benzyloxycarbonyloxy] succinimide perfluorodecyl)phenyl]-1-phenylmethyl chloride
C20H14F13NO5 O C30H20ClF17O
O
FW: 595.31 N FW: 754.91
[556050-48-7] O O
[865758-37-8]
O Cl
F3C(F2C)5 F3C(F2C)7
05656-1G-F 1g
05656-5G-F 5g OCH3
672149-1G 1g
N-[4-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-Heptadecafluorodecyl)
benzyloxycarbonyloxy]succinimide 1,1-Di-(4-methoxyphenyl)-1-[4-(1H,1H,2H,2H- 8
C22H14F17NO5 O perfluorodecyl)phenyl]methanol, 97%
O
FW: 695.32
Fluorous Peptide
Synthesis
N C31H23F17O3 OCH3
O O
[556050-49-8] O FW: 766.49
F3C(F2C)7
[865758-47-0]
14944-1G-F 1g OH
F3C(F2C)7
14944-5G-F 5g
C14H13F9O2 672696-1G 1g
OH
FW: 384.24
F3C(F2C)3 O
Diisopropyl(3,3,4,4,5,5,6,6,6-nonafluorohexyl)silane, >95%
01452-1G-F 1g C12H19F9Si
FW: 362.35 Si H
alcohol 18976-1G-F 1g
C16H13F13O2
OH
FW: 484.25 Diisopropyl(3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl)silane,
F3C(F2C)5 O
>95%
67772-1G-F 1g C14H19F13Si
67772-5G-F 5g FW: 462.37 Si H
[356056-14-9] F3C(F2C)5
4-(4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11- 00454-1G-F 1g
Heptadecafluoroundecyloxy)benzyl alcohol 00454-5G-F 5g
C18H13F17O2
OH
FW: 584.27 Diisopropyl(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadeca-
F3C(F2C)7 O
fluorodecyl)silane, >95%
97071-1G-F 1g C16H19F17Si
97071-5G-F 5g FW: 562.38 Si H
[356056-15-0] F3C(F2C)7
08431-1G-F 1g
4-(3,3,4,4,5,5,6,6,7,7,8,8,8-Tridecafluorooctyl)benzyl alcohol,
>97.0%
C15H11F13O
OH
FW: 454.23
[356055-76-0] F3C(F2C)5
16638-1G-F 1g
s i g m a - a l d r i c h . c o m
16638-5G-F 5g
73028-5MG 5 mg
FluoroFlash® SPE Cartridges, 20 grams, 60 cc tube,
73028-25MG 25 mg
40 μm particle size
4,4,5,5,6,6,7,7,8,8,9,9,9-Tridecafluorononyl azide, 8 08966-1EA-F 2 pieces
purum, >97.0%
Synthesis
Fluorous Peptide
C9H6F13N3 FluoroFlash® SPE Cartridges, 20 grams, 60 cc tube,
FW: 403.14 F3C(F2C)3 N3
40 μm particle size
[852527-60-7]
77983-5MG 5 mg 06961-1EA-F 5 pieces
77983-25MG 25 mg
FluoroFlash® TLC Plates with F254 indicator,
4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11- 8 dimension 5 cm x 10 cm
Heptadecafluoroundecyl azide, purum, >97.0%
C11H6F17N3 16888-1EA-F 10 pieces
FW: 503.16 F3C(F2C)5 N3
[852527-61-8] FluoroFlash® Silica Gel, ~40 μm particle size
97087-5MG 5 mg 08965-1EA-F 100 g
97087-25MG 25 mg
51526-5MG 5 mg
51526-25MG 25 mg
N-(4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11- 8
Heptadecafluoroundecyl)iodoacetamide, purum, >98.0%
C13H9F17INO H
FW: 645.09 F3C(F2C)6 N
I
[852527-48-1] O The fluorous products are manufactured by Fluorous Technologies, Inc.. U.S. patents
6,156,896; 5,859,247; 5,777,121 and 6,673,539 may protect use of these compounds.
55266-5MG 5 mg FluoroFlash® is a registered trademark of Fluorous Technologies, Inc.
55266-25MG 25 mg
To discuss how our expertise can benefit your next scale-up project or to obtain a quote,
contact your local Sigma-Aldrich office or visit www.safcglobal.com
Sigma-Aldrich Worldwide Locations